Follow the people · Insider

JC

Jennifer E. Cook

Insider · Director · JAZZ

Jennifer E. Cook files insider transactions with the SEC as a director of Jazz Pharmaceuticals (JAZZ). We hold 4 disclosed purchases and sales filed since 8 November 2018, 4 of them in the last 90 days.

  • Files forJAZZ
  • Disclosed buys and sells4 in all, 4 in the last 90 days
  • Last disclosure2 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 25 February 202131 August 2026Director · Jazz Pharmaceuticals (JAZZ)17 Form 4 lines · source: SEC Form 4
  • Filed 12 December 20199 July 2026Director · BridgeBio Pharma (BBIO)34 Form 4 lines · source: SEC Form 4
  • Filed 6 November 20183 June 2026Director · Denali Therapeutics (DNLI)19 Form 4 lines · source: SEC Form 4

Everything they disclosed

70 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.